Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum
- PMID: 11867191
- DOI: 10.1016/s0168-8278(01)00299-9
Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum
Abstract
Benign recurrent intrahepatic cholestasis (BRIC) is an autosomal recessive liver disease, characterised by intermittent attacks of cholestasis, which can start at any age and last for several weeks to months. Characteristically serum GGT activity is low and normal liver structure is preserved. Progressive familial intrahepatic cholestasis (PFIC) is another liver disease, characterised by severe cholestasis, starting almost invariably before 6 months of age. All patients progress to cirrhosis, liver failure and death, unless a liver transplantation is performed. We now identified four patients who presented in childhood with recurrent attacks of cholestasis, while in the course of the disease the cholestasis gradually became permanent. Although liver biopsies performed in the early stages of the disease showed normal liver architecture, late stage biopsies revealed evident fibrosis with porto-portal septa formation. In conclusion, the disease of these patients started with the clinical and histopathological characteristics of BRIC but progressed to PFIC.
Similar articles
-
Endoscopic nasobiliary drainage: an effective treatment option for benign recurrent intrahepatic cholestasis (BRIC).BMJ Case Rep. 2017 May 5;2017:bcr2016218874. doi: 10.1136/bcr-2016-218874. BMJ Case Rep. 2017. PMID: 28476903 Free PMC article.
-
Genetic cholestasis: lessons from the molecular physiology of bile formation.Can J Gastroenterol. 2000 Mar;14(3):233-8. doi: 10.1155/2000/514172. Can J Gastroenterol. 2000. PMID: 10758420 Review.
-
Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review.Acta Gastroenterol Belg. 2012 Dec;75(4):405-10. Acta Gastroenterol Belg. 2012. PMID: 23402083 Review.
-
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.Hepatology. 2010 May;51(5):1645-55. doi: 10.1002/hep.23539. Hepatology. 2010. PMID: 20232290
-
Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile.Gastroenterology. 2003 Oct;125(4):1227-34. doi: 10.1016/s0016-5085(03)01199-5. Gastroenterology. 2003. PMID: 14517804
Cited by
-
Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.World J Gastroenterol. 2012 Nov 28;18(44):6504-9. doi: 10.3748/wjg.v18.i44.6504. World J Gastroenterol. 2012. PMID: 23197899 Free PMC article.
-
The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency.PLoS One. 2016 Apr 6;11(4):e0153114. doi: 10.1371/journal.pone.0153114. eCollection 2016. PLoS One. 2016. PMID: 27050426 Free PMC article.
-
Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene.Case Rep Gastroenterol. 2022 Mar 4;16(1):110-115. doi: 10.1159/000522145. eCollection 2022 Jan-Apr. Case Rep Gastroenterol. 2022. PMID: 35431768 Free PMC article.
-
Current and future therapies for inherited cholestatic liver diseases.World J Gastroenterol. 2017 Feb 7;23(5):763-775. doi: 10.3748/wjg.v23.i5.763. World J Gastroenterol. 2017. PMID: 28223721 Free PMC article. Review.
-
Coronavirus disease 2019 (COVID-19) as a potential trigger for benign recurrent intrahepatic cholestasis.Clin Case Rep. 2022 Mar 10;10(3):e05557. doi: 10.1002/ccr3.5557. eCollection 2022 Mar. Clin Case Rep. 2022. PMID: 35310310 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous